JAMA Network December 4, 2025
Colleen Carey, Matthew L. Maciejewski

With passage of the 2022 Inflation Reduction Act, the US Medicare program gained the authority to negotiate prices for single-source prescription drugs, which account for the highest Medicare expenditures and lack generic...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Pharma, Pharma / Biotech
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable
Medicare Telehealth, Hospital-at-Home Flexibilities In Danger As Partial Government Shutdown Threat Rises
Reengineering ACOs To Make Medicare Competitive
Medicare cuts are destroying independent rural medical practices [PODCAST]

Share Article